[{"id":"8a5250ad-f3b6-42f8-b24b-850d6478ad00","acronym":"","url":"https://clinicaltrials.gov/study/NCT05274451","created_at":"2022-03-10T13:52:49.005Z","updated_at":"2024-07-02T16:35:16.777Z","phase":"Phase 1","brief_title":"A Study to Investigate LYL797 in Adults With Solid Tumors","source_id_and_acronym":"NCT05274451","lead_sponsor":"Lyell Immunopharma, Inc.","biomarkers":" ROR1","pipe":"","alterations":" ","tags":["ROR1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e LYL797"],"overall_status":"Recruiting","enrollment":" Enrollment 54","initiation":"Initiation: 03/29/2022","start_date":" 03/29/2022","primary_txt":" Primary completion: 03/01/2025","primary_completion_date":" 03/01/2025","study_txt":" Completion: 09/01/2026","study_completion_date":" 09/01/2026","last_update_posted":"2024-03-01"}]